Supernus Pharmaceuticals to Host First Quarter 2014 Earnings Conference Call
Published: Apr 29, 2014
ROCKVILLE, Md., April 29, 2014 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq:SUPN), a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, today announced that the Company expects to report the quarter ending March 31, 2014 financial results after the close of the U.S. financial markets Monday, May 12, 2014.
Help employers find you! Check out all the jobs and post your resume.